Treatment of migraine: a review of disease burden and an update on the therapeutic landscape for pharmacists-Reference-Cited by-同舟云学术

Treatment of migraine: a review of disease burden and an update on the therapeutic landscape for pharmacists

Published:2020-12-05 Issue:2 Volume:37 Page:75-86
ISSN:1172-0360
Container-title:Drugs & Therapy Perspectives
language:en
Short-container-title:Drugs Ther Perspect

Author:

Patel Nishil,Barnhart Rebecca,Konkol Paul,Varda Josephine,Nelson Rob,Smith Tim

Funder

Amgen, Inc

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40267-020-00801-2.pdf

Reference92 articles.

1. Raffaelli B, Reuter U. The biology of monoclonal antibodies: focus on calcitonin gene-related peptide for prophylactic migraine therapy. Neurotherapeutics. 2018;15(2):324–35.

2. Tepper SJ. History and review of anti-calcitonin gene-related peptide (CGRP) therapies: from translational research to treatment. Headache. 2018;58(Suppl 3):238–75.

3. Silberstein SD, Marcus DA. Sumatriptan: treatment across the full spectrum of migraine. Expert Opin Pharmacother. 2013;14(12):1659–67.

4. Ashkenazi A, Blumenfeld A. OnabotulinumtoxinA for the treatment of headache. Headache. 2013;53(Suppl 2):54–61.

5. American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1–18.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Design Thinking to Understand the Reason for Headache Referrals and Reduce Referral Rates;Neurology Clinical Practice;2024-12

2. Migraine Management in Community Pharmacies: Knowledge, Attitude and Practice Patterns of Pharmacists in Saudi Arabia;Pharmacy;2023-09-24

3. Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process;Cephalalgia;2022-07-05

4. Sex Differences in Chronic Migraine: Focusing on Clinical Features, Pathophysiology, and Treatments;Current Pain and Headache Reports;2022-02-26

5. Corrections to: Treatment of migraine: a review of disease burden and an update on the therapeutic landscape for pharmacists;Drugs & Therapy Perspectives;2021-01-06